Keep your critical coding and billing tools with you no matter where you work.
Create your Find-A-Code account today!
tci Part B Insider - 2004 Issue 18
PHYSICIAN NOTES: Don't Close Off All Off-Label Uses For Oral Chemo Drugs, ASCO Urges
The Centers for Medicare & Medicaid Services proposes to limit coverage for oral chemotherapy drugs to uses listed by the Food & Drug Administration in a drug coverage demonstration project mandated by the Medicare Modernization Act.
But the American Society for Clinical Oncology warns in a recent letter to CMS that the demonstration project will exclude from coverage "at least one significant oral drug that is regarded as an extremely important component of treatment for a deadly blood cancer that strikes many Medicare beneficiaries." ASCO points out that CMS is required to consider off-label uses of cancer...
To read the full article, sign in and subscribe to tci Part B Insider.
Keep pace with evolving Medicare regulations with timely analysis of critical updates interpreted in an easy-to-follow, easy-to-apply format. Your subscription to TCI’s Part B Insider will equip you to navigate code and guideline changes, CCI edits, and revisions to modifiers, the fee schedule, OIG target areas, and more.
Current newsletters added each month
Fully searchable archives - over 4800 articles
ALL years/issues back to 2003 organized by year and issue
Codes mentioned in articles are linked to Code Information pages
Code Information pages link back to related articles
This feature is currently unavailable for online purchase. For more information, please call 801-770-4203 or Contact Us.